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Abstract
Fragments of G protein-coupled receptors (GPCRs) are widely used as models to investigate these
polytopic integral-membrane, signal-transducing molecules but have proven difficult to prepare in
quantities necessary for NMR analyses. We report on the biosynthesis of two double transmembrane
(TM) containing fragments of Ste2p, the - factor GPCR from the yeast Saccharomyces cerevisiae.
Ste2p(G31-G110) [TM1-TM2] and Ste2p(A231-S339) [TM6-TM7-CT40] were expressed as TrpLE
fusion proteins in  Escherichia coli and released by CNBr cleavage. Expression yields were optimized
using different strains and induction parameters, and by performing CNBr cleavage directly on 
inclusion bodies. Non-labeled and uniformly labeled [15N]-TM1-TM2 and TM6-TM7-CT40, as well as
uniformly labeled [15N,13C]-TM1-TM2 and TM1-TM2 selectively  labeled with [15N-Ala],
[15N-Phe], [15N-Leu], [15N-Ile], and [15N-Val] were prepared. Yields of target peptides with >95%
homogeneity varied from 3 mg/L of fermentation  ([15N]-TM6-TM7-CT40) to 20 mg/L (selectively
labeled TM1-TM2). The high level biosynthesis, CNBr processing and the efficient purification yields
allowed the initiation  of a comprehensive biophysical analysis of TM1-TM2 and TM6-TM7-CT40.
Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis showed that TM1-TM2 was 
monomeric in this micellar environment whereas TM6-TM7-CT40 migrated as a dimer. CD analysis
indicated that TM1-TM2 was highly helical in SDS
and1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-RAC-(1-glycerol)] but has a tendency to aggregate in
dodecylphosphocholine micelles. Similar results were found with TM6-TM7-CT40. Conditions for
NMR measurements were optimized, and both TM1-TM2 and TM6-TM7- CT40 exhibited more that
90% of the expected crosspeaks in the [15N,1H]-HSQC spectrum. These findings set the stage for the
determination of the 3D structure of these  large domains of a GPCR in micelles using high-resolution
NMR.  
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2Abstract
Fragments of G protein-coupled receptors (GPCRs) are widely used as models to 
investigate these polytopic integral–membrane, signal-transducing molecules but have 
proven difficult to prepare in quantities necessary for NMR analyses. We report on the 
biosynthesis of two double transmembrane (TM) containing fragments of Ste2p, the -
factor GPCR from the yeast Saccharomyces cerevisiae. Ste2p(G31-G110) [TM1-TM2] 
and Ste2p(A231-S339) [TM6-TM7-CT40] were expressed as TrpLE fusion proteins in 
Escherichia coli and released by CNBr cleavage. Expression yields were optimized using 
different strains and induction parameters, and by performing CNBr cleavage directly on 
inclusion bodies. Non-labeled and uniformly labeled [15N]-TM1-TM2 and TM6-TM7-
CT40, as well as uniformly labeled [15N,13C]-TM1-TM2 and TM1-TM2 selectively 
labeled with [15N-Ala], [15N-Phe], [15N-Leu], [15N-Ile], and [15N-Val] were prepared. 
Yields of target peptides with >95% homogeneity varied from 3 mg/L of fermentation 
([15N]-TM6-TM7-CT40) to 20 mg/L (selectively labeled TM1-TM2). The high level 
biosynthesis, CNBr processing and the efficient purification yields allowed the initiation 
of a comprehensive biophysical analysis of TM1-TM2 and TM6-TM7-CT40. Sodium 
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis showed that TM1-TM2 was 
monomeric in this micellar environment whereas TM6-TM7-CT40 migrated as a dimer. 
CD analysis indicated that TM1-TM2 was highly helical in SDS and 1-palmitoyl-2-
hydroxy-sn-glycero-3-[phospho-RAC-(1-glycerol)] but has a tendency to aggregate in 
dodecylphosphocholine micelles. Similar results were found with TM6-TM7-CT40. 
Conditions for NMR measurements were optimized, and both TM1-TM2 and TM6-TM7-
CT40 exhibited more that 90% of the expected crosspeaks in the [15N,1H]-HSQC 
spectrum. These findings set the stage for the determination of the 3D structure of these 
large domains of a GPCR in micelles using high-resolution NMR.
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3Introduction
The structural study of G protein–coupled receptors (GPCRs) remains a challenging 
problem.  Of the 1000 or so known GPCRs there is only one high resolution structure 
available, that of rhodopsin1.  Expression and purification of these highly hydrophobic 
proteins in levels sufficient for biophysical analysis as well as the inherent flexibility of 
GPCRs and their requirement for membrane-like environments to insure proper folding 
are limiting steps in structure determination. 
Many groups have studied fragments of GPCRs and other integral membrane proteins 
including individual transmembrane domains (TMs), loop regions, and N-terminal and C-
terminal domains to circumvent some of the limitations encountered with the intact 
protein. These fragments are prepared most often by chemical synthesis2-15. Double 
transmembrane domain peptide fragments from integral membrane proteins including 
MerFt16,17, the µ-opioid receptor18 and the cystic fibrosis transmembrane conductance 
regulator19 have been expressed and purified. There are also reports of the isotopic 
labeling of double transmembrane fragments of integral membrane proteins for use in 
NMR studies16,17,20-22. 
Recently, the direct expression of 18 full-length prokaryotic integral membrane 
proteins in amounts necessary to generate [15N,1H]-HSQC spectra in membrane mimetic 
micelles was reported23. These integral membrane proteins contained 1-4 TMs and were 
considerably smaller than eukaryotic GPCRs. To date all attempts to generate and study 
full-length GPCRs have met with limited success. Expression of full-length and truncated 
versions of the olfactory receptor OR5 was optimized in E. coli24.  The amount of protein 
expressed was sufficient to perform several biophysical analyses, but the protein was not 
isotopically labeled for NMR structural studies.  An exciting study reported the 
expression and purification of uniformly [15N,2H]-labeled vasopressin V2 receptor in 
high enough levels to perform some initial HSQC-TROSY analysis25,26. However, only 
about 80 peaks out of 349 were observed in the resulting spectrum. These recent results 
emphasize the difficulties facing NMR spectroscopists who are attempting to determine 
the structures of full-length GPCRs in the presence of micelles.
Despite the progress in expressing full-length GPCRs, major challenges remain in 
structural analysis by NMR because of the size of the GPCR/micellar complex, the poor 
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4dispersion of 1H chemical shifts of these highly helical proteins and the redundancy of 
residues found in transmembrane regions of these receptors. Simplification of the spectra 
by studying smaller domains of the GPCR should aid in these analyses. Such an approach 
is often taken in X-ray crystallography wherein determination of a domain of a protein 
may aid in solving the structure of the full protein. Several NMR structures of 
multidomain membrane peptides in organic solvents including the seventh 
transmembrane domain and CT tail of the yeast -factor receptor27, the double TM 
domains of the CB2 cannabanoid receptor20 and the human glycine transporter21 are now
available. However, although we recently reported a structure for a fragment of Ste2p 
containing one TM in detergents28, no solution NMR study of a double TM fragment 
from a GPCR in a micellar complex has been described in the literature. Micelles are a 
more desirable background than organic-aqueous media for the analysis of integral 
membrane proteins23. However, to identify optimum spectroscopic conditions, screening 
of multiple detergents must be performed under a variety of conditions (i.e., pH, 
concentration of the detergent, temperature) necessitating multimilligram quantities of 
[15N]-labeled proteins or peptide fragments.    
In this paper, the expression and purification of two double TM-containing 
polypeptides, an N-terminal segment spanning TM1 and TM2 (residues 31-110) and a C-
terminal segment spanning TM6 and TM7 (residues 231-339) of the Ste2p -factor 
receptor are reported (Figure 1).  The target regions of Ste2p, expressed as fusion proteins 
tagged with the TrpLE protein, were then processed by CNBr cleavage to release 
double TM containing polypeptides. Fusion protein expression was increased by 
changing host strains and induction parameters. Purification of the peptide was enhanced 
by direct CNBr cleavage of inclusion body preparations and using various HPLC elution 
conditions. From 3 to 20 mg of the desired polypeptide was obtained per liter of culture 
after RP-HPLC purification.   Unlabeled peptide was used for CD analysis and for 
investigation of the molecular state of these molecules in SDS gels. [15N]-, and [15N-
amino acid]-selectively labeled peptides were studied in various detergents to select 
conditions for measurement of high quality NMR spectra. 
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5Materials and Methods
Cloning and mutagenesis of Ste2p TM1-TM2. To generate a plasmid encoding TM1-TM2 
the pSW0229 vector was digested with HindIII-BamHI (NEB) to remove the TM6 insert 
and the remaining vector was gel purified. In parallel, an insert encoding Ste2p(G31-
T110) was generated by amplifying the appropriate region of Cys-less Ste2p, pBEC230, 
using primers containing HindIII and BamHI restriction sites and the PCR product was 
digested and ligated into  cut pSW02. The plasmid generated, pSWM1M2 (C59S), 
encoded the TrpLE leader sequence fused to DNA encoding TM1-TM2 Ste2p(G31-
T110,C59S). The ligation products were transformed into E. coli, the plasmid DNA was 
isolated, and the sequence was verified at the University of Tennessee DNA sequencing 
core facility. 
In order to perform CNBr cleavage to remove TrpLE without cleavage of 
Ste2p(G31-T110,C59S) itself, mutations of the Met residues within TM1-TM2 were 
performed using double-stranded mutagenesis, which is a modified method based on the 
Stratagene QuikChange mutagenesis protocol (Stratagene, La Jolla, CA).  Briefly, two 
sets of primers were designed to first generate the mutation M54L in the C59S 
background [pSWM1M2 (M54L, C59S)] and then to generate the additional mutations 
M69V and M71I (pLC01). Primer melting temperatures and other characteristics were 
determined at www.basic.northwestern.edu/biotools/oligocalc.html.  The 50 µl 
elongation reaction was performed under the following conditions: 400 ng template 
DNA, 50 pmol of each primer, 0.2 mM dNTPs, 1X PCR buffer (provided with 
polymerase), 2.5 mM MgSO4 and 3.75 units of DNA polymerase (Takara and 
Invitrogen).  The reaction was carried out in a thermalcycler set for the following 
program: 1 cycle at 94ºC for 3 min; 35 cycles at:  94ºC for 30 sec, 55ºC for 30 sec, and 
68ºC for 5 min; and 1 cycle at 68ºC for 20 min. The reaction mixture was subjected to 
digestion (80 units, at 37°C) of DpnI (NEB), which specifically cuts the methylated 
template DNA, cleaned up using the Wizard DNA Clean Up Kit (Promega), and then 
transformed into MAX efficiency DH5 Competent Cells (Invitrogen). The final plasmid 
generated, pLC01, coded for TM1-TM2 Ste2p(G31-T110, M54L, C59S, M69V, M71I) 
(Table 1) as verified by DNA sequence analysis.
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6Cloning and mutagenesis of Ste2p TM6-TM7-CT40. Plasmid pGA314.Cys-
less.STE2.FT.HT31 was used as a template for site-directed mutagenesis to generate 
M250A and M294A mutations32,33. The resulting plasmid was then used as template to 
amplify a region of STE2 encoding residues R231 through S339 including NcoI and XhoI 
sites for cloning into pET32b (Invitrogen). The sequence of the new plasmid pKLS02 
(Table 1) was verified at the University of Tennessee DNA sequencing core facility. The 
TM6-TM7-CT40 region of Ste2p was amplified from pKLS02 and introduced into the 
pREJ02 vector27 that was digested with HindIII-BamHI. The ligation products were 
transformed and plasmid DNA was isolated and sequenced for insert verification. The 
final plasmid generated, pREJ04, coded for TM6-TM7-CT40 Ste2p(R231-S339; M250A, 
C252S, M294A) as a TrpLE fusion protein (Table 1).
Optimization of Expression from pLC01 and pREJ04 in BL21(DE3)pLysS, 
BL21Star(DE3)pLysS, and BL21-AI. Plasmids, pLC01 and pREJ04, were separately
transformed into  BL21(DE3)pLysS, BL21Star(DE3)pLysS and BL21-AI cells 
(Invitrogen).  The transformed BL21(DE3)pLysS and BL21Star(DE3)pLysS strains were
grown in 50 ml Luria Broth (LB) cultures containing ampicillin (Amp; 200 µg/mL) and 
chloramphenicol (Cam; 34 µg/mL). The transformed BL21-AI cells were grown in LB 
containing Amp (200 µg/mL) only. The cells were grown at 37°C with shaking at 250 
rpm. BL21(DE3)pLysS and BL21Star(DE3)pLysS strains were induced with 1 mM IPTG 
at OD600 of 0.6 and the BL21-AI cells were induced with 0.2% L-arabinose at OD600 of 
0.4. Cells were collected every hour to follow the expression of the fusion protein (FP) 
and inclusion body (IB) preparations were generated for SDS-PAGE analysis as 
previously described27. Optimization of expression from both plasmids in BL21-AI was 
performed with varying amounts of L-arabinose both with and without IPTG.
Large-scale Expression from pLC01 and pREJ04 in BL21-AI. A 1L culture of BL21-AI 
cells bearing plasmids pLC01 or pREJ04 was grown in LBAmp200 as above and 
expression was induced with 0.5-1% L-arabinose and 1 mM IPTG at 37°C for 5 hours. 
These cells were pelleted and IBs were generated for purification as described 
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7previously27.  For IB samples that were used for direct cleavage, the final solubilization 
step in GnHCl was not used.  
Expression of [15N]- or [15N,13C]-labeled fusion proteins was performed in  
minimal media containing 15NH4Cl or 15NH4Cl/13C-glucose. For TM1-TM2-FP, prior to 
induction, 2 L of LB were inoculated with 100 ml of an overnight culture of pLC01 in 
BL21-AI.  Cells were grown at 37ºC with shaking until they reached an OD600 of 
approximately 0.4.  The cells were harvested by centrifuged (3000 rpm, 15 minutes) and 
the pellets were resuspended in an equal volume (2 L) of minimal media containing 1 g 
15NH4Cl, 20 mM KH2PO4, 48 mM Na2HPO4, 8.6 mM NaCl, 0.4% glucose or 13C-
glucose, 2 mM MgSO4, 0.1 mM CaCl2 and 200 µg/ml ampicillin.  The cells were then 
induced with L-arabinose (0.5-1%) and 1 mM IPTG and incubated under optimized 
conditions as discussed in the Results. Selectively labeled TM1-TM2-FP was grown in 
minimal media without NH4Cl as above, and the media were supplemented with added 
amino acids (1 g/L of the [15N]-labeled amino acid of choice and 0.5g/L of all the other 
unlabeled amino acids).  TM6-TM7-CT40-FP, encoded by pREJ04, was expressed in 
[15N]-minimal media as described above but induced only with L-arabinose.
Purification of fusion proteins and peptides by RP-HPLC. Purification of TM1-TM2-FP  
and TM6-TM7-CT40-FP was performed on either preparative or analytical Zorbax 
300SB-C3 reversed-phase columns at 60ºC using gradients from 30% to 90% solvent B, 
where solvent A is 90% water, 10% isopropanol, 0.1% TFA and solvent B is 90% 
acetonitrile, 10% isopropanol, 0.1% TFA. After CNBr cleavage (see below) the TM1-
TM2 and TM6-TM7-CT40 peptides were purified with the same columns at 60ºC with 
gradients of 50-90% or 40-80% solvent B, respectively. Analysis was performed using an 
analytical Zorbax 300SB-C3 column at 60ºC with a 30-90% solvent B gradient.
Cyanogen bromide cleavage of TM1-TM2-FP. Cyanogen bromide cleavage of the TM1-
TM2-FP was utilized to release TM1-TM2 from the TrpLE.  About 1.6 mg of TM1-
TM2-FP was cleaved with 1 M CNBr in ~35 µl 60% TFA and the reaction progress was 
followed by RP-HPLC.  After 2.5 hours at room temperature in the dark the entire 
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8reaction mixture was loaded onto the analytical C3 column and RP-HPLC was performed 
as described above.  
CNBr Cleavage of TM1-TM2-FP and TM6-TM7-CT40-FP directly in inclusion bodies.
TM1-TM2-FP IB pellets were solubilized in 70% TFA for CNBr cleavage. The cleavages 
were followed over time by analytical HPLC on a Zorbax 300SB-C3 column.  For large 
scale purifications TM1-TM2-FP IB pellets from ~125-250 ml of cell culture were 
dissolved in 70% TFA (500-600 µL) and cleaved with 1 M CNBr for 1-2 hours at room 
temperature.  The cleaved peptide was purified as described above. Similarly, TM6-TM7-
CT40-FP inclusion bodies from 125 mL cultures were dissolved in 80% TFA (500 µL), 
cleaved with 1-2 M CNBr for at least 2 hours at room temperature and purified as 
described above.
Circular Dichroism (CD) Spectroscopy. For CD analysis of TM1-TM2 and TM6-TM7-
CT40 in organic-aqueous solvents, micelles and solutions of vesicles, stock solutions of 
these peptides were first prepared in 50% TFE/water. Concentration of the peptides was 
determined by UV spectroscopy at 280 nm using an extinction coefficient of 9570 M-1 
cm-1 for TM1-TM2 and 8230 M-1 cm-1 for TM6-TM7-CT40 peptide34. Appropriate 
volumes were lyophilized to yield 0.1 mg of peptide per vial. Solutions (20mM) of 
sodium dodecyl sulfate (SDS), dodecylphosphocholine (DPC) and 1-palmitoyl-2-
hydroxy-sn-glycero-3-[phospho-RAC-(1-glycerol)] (LPPG) in 10 mM phosphate buffer 
pH 5 or 6 were sonicated at 50 °C for 15 minutes using an S3000 unit (Misonix, Inc., 
Farmingdale, NY) equipped with a 2.5 inch Cup Horn sonicator operated at output power 
~50 W. One half of the obtained solution was used as a blank for CD measurement, while 
the other half was used to solubilize the lyophilized peptide powder. The peptide 
solutions in detergents were sonicated as described above for 15 minutes or until the 
solution clarified. The detergent/lipid-to-peptide weight ratios were between 100:1 and 
200:1.
The circular dichroism (CD) spectra of the peptides were recorded on an AVIV 
model 62-DS CD instrument (AVIV Associates, Lakewood, NJ). Quartz cuvettes with 
path length of 0.2 mm were used. All spectra were obtained by averaging 3-5 scans in a 
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9spectral window from 260 nm to 185 nm at an interval of 1 nm, slit width 1 or 2nm, with 
a 5 s integration time at each wavelength. CD spectra on blanks, corresponding to the 
different media without peptide, were collected at the same instrumental conditions and 
subtracted from the spectra containing the protein. CD intensities are expressed as mean 
residue ellipticities (deg cm2 dmol-1). 
Micellar domain mixing experiment and SDS-PAGE analysis. TM1-TM2 and TM6-TM7-
CT40 were solubilized in 25% TFE to a final concentration of 1 µg/µl. The peptides were 
aliquoted so that the final reactions contained 25 µM peptide.  These were mixed with 20 
mM phosphate buffer, pH 6 with either 10 mM or 100 mM SDS.  The samples were 
sonicated at 50°C for 5 minutes and SDS loading buffer (4% SDS, 12% glycerol, 256 
mM 2-mercaptoethanol, 50 mM Tris-HCl, pH 6.8, and a small amount of Brilliant Blue 
G) was added immediately prior to the loading of the gel.
Mass Spectrometry and Estimation of Isotopic Incorporation. Mass spectra were 
measured using an Agilent 1100 LC/MS instrument equipped with an electrospray ion 
source and an Ion Trap detector. The proteins were analyzed directly after elution from 
the HPLC or dissolved in a 1,1,1,3,3,3-hexafluoro-2-propanol/acetic acid (1:1 v/v) 
mixture and injected into the LC/MS instrument running with an acetonitrile/water 
(+0.5% acetic acid) chromatographic eluent. MS data was used to estimate percentage of 
isotopic labeling during 15N and 13C incorporation.  Incorporation was determined using 
the following formula:
[(Labeled MWobserved-Unlabeled MWcalculated)/(Labeled MWcalculated-Unlabeled MWcalculated)]  x 100
NMR Sample Preparation. Uniformly labeled [15N]-TM1-TM2 and [15N]-TM6-TM7-
CT40 peptides (0.6-0.7 mg) were dissolved in 330 µL of 100 mM detergent solution (d25-
SDS, d38-DPC or LPPG) in 20mM phosphate buffer pH 6 prepared in an H2O/D2O (9:1) 
mixture. Buffer solution also contained 0.02% NaN3 and traces of 2,2-dimethyl-2-
silapentane-5-sulfonate sodium salt (DSS) used to reference 1H chemical shifts. 15N 
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10
chemical shifts were referenced indirectly35. Final peptide concentration was ~0.2 mM 
and the peptide:detergent molar ratio was 1:500. Before dissolving the peptide, the 
detergent solution in buffer was sonicated for 10 minutes at 50°C using a S3000 Misonix 
sonicator. The peptide/detergent mixtures were also sonicated for 10 minutes at 50°C and 
then transferred to a Shigemi NMR tube (Shigemi, Inc., Allison Park, PA). Nitrogen-
proton heteronuclear single quantum correlation ([15N,1H]-HSQC) NMR spectra were 
recorded at 50°C on a three-channel Varian UNITY INOVA 600 MHz NMR 
spectrometer (Varian NMR Instrument, Palo Alto, CA) equipped with a z-axis pulsed-
field-gradient and a Varian 5-mm [15N,13C,1H] triple resonance probe. 
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Results
Design and Generation of pLC01[Ste2p(G31-T110, M54L, C59S, M69V, M71I)] and 
pREJ04 [Ste2p(R231-S339, M250A, C252S, M294A)] by cloning and mutagenesis. Our 
choice of the exact regions of Ste2p to clone was based on a buried surface area analysis 
of a computer model of Ste2p36, hydrophobicity analysis37, and functional significance 
based on interactions determined in the intact receptor38-40. The amount of buried surface 
area between various TMs was calculated using the NACCESS software41 and provides 
data indicative of the number of contacts that are present between the TMs. The TM1-
TM2 region of Ste2p, G31-G110, had the highest buried surface area between the two 
TM domains (1349 Å2) of any pair of TMs in this GPCR (Table 2). Although TM6-TM7-
CT40 had a much lower buried surface area, this region of Ste2p and the TM6 of other 
GPCRs have been shown to be extremely important in signal transduction40,42-44. The 
TM1-TM2 and TM6-TM7-CT40 regions were cloned to produce expression vectors 
containing the TrpLE protein upstream of the double domain sequence to direct the 
expressed protein into inclusion bodies. All constructs contained a Met residue between 
the TrpLE protein and the Ste2p peptide to permit removal of TrpLE by CNBr 
cleavage.  Any native Met residues within the double domain region were mutated as 
described in the Methods Section to prevent internal cleavage of the Ste2p domain. 
Native methionines were replaced with residues of similar hydrophobicity to maximize 
the probability that such replacements in the full-length receptor would be fully 
functional as shown in previous studies 45.  The final constructs generated were pLC01 
and pREJ04 which expressed TM1-TM2-FP and TM6-TM7-CT40-FP, respectively.
Expression of double domain fusion proteins in BL21(DE3)pLysS. The plasmid pLC01 
was expressed in BL21(DE3)pLysS in LB (Figure 2A, lanes 1-2).  Although expression 
of the TM1-TM2-FP was observed, SDS-PAGE analysis indicated that the level was 
considerably lower than that previously found for pREJ02 (EL3-TM7-CT40-FP)27. Since 
expression is often reduced in minimal medium required in isotope labeling experiments, 
we were concerned that it would be difficult to isolate sufficient TM1-TM2 peptide after 
cleavage for NMR structural analyses.  Optimization of fusion protein expression was 
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performed by varying induction temperature and OD600 at time of induction in 
BL21(DE3)pLysS but no increase in expression was observed (data not shown).  
Attempts to express TM6-TM7-CT40-FP from pREJ04 in BL21(DE3)pLysS cells 
resulted in low protein levels compared to TM1-TM2 under similar conditions (Figure 
2A and 2B, lanes 1-2).  The expression increased slightly by growing the cells at 30°C 
prior to induction, and then increasing to 37°C after IPTG addition. However, in both
cases the levels of fusion protein produced were still relatively low. Because of the low 
expression levels encountered in BL21(DE3)pLysS cells, different E. coli expression 
strains were evaluated.
Expression of double domain fusion proteins in BL21-AI and BL21Star(DE3)pLysS. Two 
new expression strains were evaluated to determine if these might be used to increase 
protein yield.  BL21Star(DE3)pLysS contains a mutation of the rne gene that encodes a 
truncated RNase E protein. BL21-AI has the T7 RNA polymerase gene as a chromosomal 
insertion that is under the regulation of the araBAD promoter, as opposed to a  lysogen 
used for expression in BL21(DE)pLysS. Both strains have been used for expression of 
toxic proteins. SDS-PAGE analysis on IBs from small cultures indicated similar 
expression of TM1-TM2-FP in BL21-AI compared to the BL21(DE3)pLysS (Figure 2A, 
lanes 3-4), but increased expression for TM6-TM7-CT40-FP (Figure 2B, lanes 3-4). In 
contrast, expression in BL21Star(DE3)pLysS either resulted in induction of a protein 
with incorrect MW (TM1-TM2-FP) or an expression yield similar to that in 
BL21(DE3)pLysS (TM6-TM7-CT40-FP)(Figure 2A and B, lanes 5-6) .
The growth and expression in BL21-AI was optimized as to the amount of L-
arabinose added to each culture. TM1-TM2-FP was expressed at similar levels with 0.5-
1% L-arabinose followed by incubation for 5 hours after inducer addition.  Though these 
levels were similar to the expression in BL21(DE3)pLysS, the growth of BL21-AI cells 
reached the induction OD600 level 1-2 hours faster than BL21(DE3)pLysS cells and gave 
optimal expression levels at earlier growth times.  TM6-TM7-CT40-FP was expressed 
best with 1% L-arabinose with incubation for 6 hours after inducer addition.
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Optimization of expression of double domain fusion proteins in BL21-AI in minimal
media. Conditions that resulted in the highest expression of proteins, TM1-TM2-FP and 
TM6-TM7-CT40-FP, encoded by pLC01 and pREJ04, respectively, in BL21-AI in 
minimal media were determined.  Dilutions of overnight cultures of the transformed cells 
(100 ml LBAmp200) were grown at 37°C at 250 rpm until they reached an OD600 of 0.4. 
The cells were then pelleted and resuspended in 50 ml minimal medium cultures 
containing 15NH4Cl, induced with the appropriate inducer(s) as determined above and 
protein expression continued at room temperature or 37°C overnight. Expression was 
analyzed by SDS-PAGE and compared to expression in the original strain, 
BL21(DE3)pLysS (Figure 2C).  Expression of TM1-TM2-FP was similar in both strains 
using optimized conditions. Conversely, the expression of TM6-TM7-CT40-FP was 
much better in BL21-AI.  Most importantly we observed better expression in M9 minimal 
medium as compared to LB medium (Figure 2C).
The achievement of high expression in minimal medium allowed us to prepare 
sufficient quantities of fusion protein for NMR analysis. Optimal expression of TM1-
TM2-FP occurred with growth at 37°C to 0.4 OD600, induction with 0.5% L-arabinose 
and 1 mM IPTG, followed by incubation with shaking at room temperature overnight.  
15N incorporation into the TM1-TM2-FP, under these optimized conditions, was high as 
verified by ESI-MS after purification of the TM1-TM2-FP (MWexpected=22604 Da; 
MWobserved=22589.7, or 95% incorporation). Doubly-labeled [15N,13C]-TM1-TM2-FP was 
generated by expression in BL21-AI in 1L minimal medium containing 13C-glucose and 
15NH4Cl under the optimized conditions described above.  Purification of the fusion 
protein for MS analysis showed excellent incorporation (96%) of both the 13C and the 15N 
moieties (MWexpected= 23614, MWobserved=23563.0).
Cells expressing the TM6-TM7-CT40-FP were grown to 0.4 OD600 at 37°C and 
pelleted, resuspended in 15N minimal medium, and then induced with 0.5% L-arabinose 
at either 37°C or room temperature overnight.  The best expression for this fusion protein 
occurred when induction was performed overnight at 37°C.  The amount of incorporation 
of the 15N into the fusion protein was 97% (MWexpected=25651.11, MWobserved=25639.85).
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Selective Amino Acid Labeling of TM1-TM2-FP. Selective labeling of amino acids has 
been shown to aid in assignments of amino acid residues in a crowded HSQC spectrum.  
To optimize the incorporation of an individual amino acid we chose [15N-Ala] because it 
is well represented in the transmembrane regions of TM1 and TM2, the labeled residue is 
relatively inexpensive, and previous studies showed minimal scrambling of the 15N label 
into other amino acid residues46.  BL21-AI containing pLC01 was grown and induced in 
BL21-AI under multiple conditions in an attempt to optimize [15N-Ala] incorporation 
(Table 3).  
Based on our previous results, we attempted to incorporate [15N-Ala] into TM1-
TM2 by directly adding this amino acid to rich medium46.  Incorporation was calculated 
using mass spectroscopy.  Using 0.5 g/L of [15N-Ala] in rich media ~50% incorporation
into TM1-TM2 was obtained. In an attempt to increase the level of incorporation we 
switched to M9 minimal medium with either 0.1 g/L or 0.5 g/L of the 19 other unlabeled 
amino acids and different amounts of [15N-Ala]. The highest incorporation was achieved 
when 0.5 g/L of unlabeled amino acids and 1 g/L of [15N-Ala] was used (52% of 
theoretical; Table 3). Though the incorporation was not higher than in LB, the amount of 
fusion protein expressed was 1.5-fold greater than that in LB likely due to the availability 
of all of the individual amino acids in the growth medium.  Using these later conditions 
TM1-TM2-FP was selectively labeled with [15N-(Val, Ile, Leu, or Phe)]. 
Cleavage of TM1-TM2-FP and TM6-TM7-CT40-FP directly in inclusion bodies. 
Purification of both fusion proteins was first attempted using a Ni2+-NTA column. 
However, the target fusion protein appeared to be washed off the column early in the 
imidazole gradient with many other proteins or was observed at multiple elution points 
(data not shown).  Next, purification of TM1-TM2-FP from inclusion bodies was 
attempted on a Zorbax 300SB-C3 Prep-HT column (21.2x150mm) with a 30-90% 
acetonitrile (0.1% TFA):water (0.1% TFA) gradient at 50°C (Figure 3A).  Six mg of 
nearly homogeneous fusion protein was obtained per liter of fermentation (Figure 3B). 
The MW of TM1-TM2-FP was 22318.0 Da (Figure 3C) as compared to a calculated 
value of 22315 Da.  Unfortunately the fusion protein bound to the HPLC column even 
after a gradient run and cross-contaminated subsequent purification attempts. Elimination 
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of sticking was observed with an acetonitrile (0.1% TFA) gradient containing 10% 
isopropanol, at 60°C. Under these enhanced conditions, 1L of fermentation in LB 
generated about 8 mg of TM1-TM2-FP when purified on a preparative scale.  However, 
the largest amount of fusion protein that could be purified during each HPLC run was 
limited to 0.5 mg. To further improve the efficiencies and the ultimate yield of TM1-TM2 
we evaluated cleavage of the TM1-TM2-FP directly from the inclusion body (IB) 
preparations.
We found that cleavage of the fusion protein directly from solubilized IBs was 
feasible using 1 M CNBr  in 70% TFA.  The reaction was followed for 4 hours at which 
time the peptide was purified by semipreparative HPLC (Figure 4A and B). Peaks for the 
TrpLE carrier protein and unreacted TM1-TM2-FP were identified by ESI-MS. The 
major peak, which eluted at about 38 minutes on the Prep-HT column (Figure 4C), was 
the expected product TM1-TM2 (Figure 4D; MWcalculated=8751.3, MWobserved=8749.2), 
and the amount of residual fusion protein was less than 7% of the starting protein (Figure 
4A-B). Cleavage and purification of [15N]- and [15N,13C]-TM1-TM2 generated 10 mg/L 
of 96% [15N] incorporated peptide (MWexpected=8852.3, MWobserved=8847.9) and 8 mg/L 
of 97% [15N,13C]-labeled peptide (MWexpected=9258.3, MWobserved=9240.5) (Figure 5).  
Selectively labeled peptides also had good yields of recovered peptide (11-20 mg/L) and
incorporation of the [15N-amino acid] was >80% as judged using mass spectrometry in all 
cases, except [15N-Ala] which was 52%.  Analysis of these selectively labeled samples of 
TM1-TM2 by NMR showed varying degrees of cross labeling (vide infra).
The TM6-TM7-CT40-FP in inclusion bodies was cleaved and the target peptide 
was purified as above, but the cleavage was incomplete and there was a significant 
amount of TM6-TM7-CT40-FP left in the reaction limiting the yield of TM6-TM7-CT40. 
Optimization of the cleavage reaction was attempted by increasing the amount of TFA to 
80% and the concentration of CNBr to 2M. The cleavage of an IB pellet from about 125 
ml culture in 80% TFA with 1M CNBr yielded 43% peptide based on HPLC peak area 
analysis with about 18% of intact FP remaining after 2.5 h reaction (Table 4).  A similar 
reaction containing 2M CNBr generated 39% peptide with 14% uncleaved FP remaining. 
Comparison of peak areas and percent yields (see Table 4) indicated that TM6-TM7-
CT40 peptide may be aggregating and remaining on the column under the purification 
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conditions tested. Under these suboptimal conditions, 1 liter of [15N] minimal media 
culture generated approximately 3 mg of 96% [15N] incorporated peptide 
(MWexpected=11898.4, MWobserved=11893.1)(data not shown).
Circular Dichroism of double domain containing peptide fragments of Ste2p.  CD 
analysis was performed on both the TM1-TM2 and TM6-TM7-CT40 peptides to 
determine their structure in membrane mimetic solvents.  In aqueous trifluoroethanol 
(1:1, v/v) TM1-TM2 showed a split * transition with a maximum at 192 nm and a 
minimum at 208 nm, and a strong n* band at 222 nm. The molar ellipticity of the 222 
nm band [] = - 28000 deg cm2decimole-1 was indicative of a highly helical polypeptide. 
(Figure 6).  In the presence of large (100-200 fold) excesses of SDS and LPPG detergent 
micelles the CD spectra of TM1-TM2 also manifested bands at 222 nm, 208 nm and 190-
195 nm (Figure 6A). In contrast distinct minima at 208 and 222 nm were not observed for 
this peptide in DPC micelles (Figure 6A) and the ellipticities of the * and n* 
peaks decreased nearly two-fold. Relative to those of TM1-TM2 the molar ellipticities for 
TM6-TM7-CT40 were lower in each of the detergent micelles and the splitting of the 
* band was greatly reduced in DPC (Figure 6B).  
Determination of the molecular state of the double domain peptides.  Modeling studies 
have shown the potential for TM-TM interactions between multiple domains in Ste2p36. 
TM2 and TM7 are hypothesized to interact between N84 and S293.  Based on these 
predictions, we wanted to determine if interactions between TM1-TM2 and TM6-TM7-
CT40 would be observed by SDS-PAGE analysis. SDS micelles containing TM1-TM2 
and TM6-TM7-CT40 were prepared in micelles alone, as well as in micelles containing 
equimolar amounts of both peptides and SDS-PAGE was performed (Figure 7).  The 
micelles were prepared at concentrations at or above the CMC for SDS.  Under our 
conditions TM1-TM2 runs as a monomer whereas TM6-TM7-CT40 runs as a dimer. We 
did not observe interactions between TM1-TM2 and TM6-TM7-CT40.  
NMR analysis of double domain peptide fragments in detergent micelles. To elucidate 
potential for high resolution structure determination of TM1-TM2 and TM6-TM7-CT40 
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by NMR spectroscopy we screened several membrane mimetic detergents preparations. 
[15N,1H,]-HSQC spectra of TM1-TM2 in SDS and LPPG exhibited excellent peak 
dispersion and well resolved crosspeaks. Of 78 expected crosspeaks for the backbone 
amide moieties, 74 were observed in both LPPG and SDS (Figure 8A-B).  [15N,1H,]-
HSQC of TM6-TM7-CT40 in LPPG exhibited 90 out of 104 expected crosspeaks (Figure 
8C). In SDS micelles, we observed a similar percentage of the expected peaks but the 
spectra showed increased line widths compared to LPPG (Figure 8D). When NMR 
analysis was attempted in DPC very few peaks were observed for TM1-TM2 and only 
~40 crosspeaks, which were significantly broadened compared to those in LPPG, were 
observed for TM6-TM7-CT40 (data not shown). Moreover, in DPC, precipitate was 
observed in the TM1-TM2 sample indicating an unstable peptide-micelle complex. 
TM1-TM2 labeled at selected amino acids ([15N-Ala]-TM1-TM2, [15N-Leu]-
TM1-TM2, [15N-Ile]-TM1-TM2, [15N-Val]-TM1-TM2, and [15N-Phe]-TM1-TM2) was 
generated as described above and HSQC spectra were measured in LPPG and SDS. As 
seen in Figure 9, the HSQC spectra of [15N-Ala]-TM1-TM2 and [15N-Leu]-TM1-TM2 
exhibited 5 and 11 peaks, respectively (Figure 9A and 9D). Incorporation of [15N-Ile] into 
TM1-TM2 led to scrambling into [15N-Val] and [15N-Leu] (data not shown). Similarly, 
incorporation [15N-Val] into TM1-TM2 resulted in 7 major peaks and 5 smaller peaks 
(see boxed peaks in Figure 9B). These scrambled crosspeaks all appeared at the 
frequencies of the 5 Ala resonances (compare Figures 9A and 9B). Finally, incorporation 
of the [15N-Phe] into TM1-TM2 resulted in 5 major peaks representing Phe as well as 
three Tyr peaks and a few other minor cross-labeled residues (data not shown). In all 
cases the primary peaks were readily distinguished from those peaks due to isotopic 
scrambling. The cross-labeling products were expected based on amino acid biosynthetic 
pathways (see 46 for a discussion and Kessler et al.47). Using these peptides we were able 
to both identify difficult to assign residues and to confirm residues that we have assigned 
by 3D NMR experiments (Zerbe and Naider, unpublished results).
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Discussion
Expression of hydrophobic integral membrane proteins in amounts sufficient for 
biophysical measurements has been a bottleneck in structural studies of these ubiquitous 
molecules.  Although fragments of integral membrane proteins provide a first alternative 
to study domains of these polytopic molecules, poor expression and purification yields of 
fragments containing two or more TMs makes these studies challenging.  In this paper we 
have examined the expression of two distinct double-TM containing peptide fragments 
from Ste2p, a GPCR from the yeast S. cerevisiae.  By changing the bacterial expression 
strain and induction parameters we have been able to obtain high level expression of
[15N]-, [15N,13C]-, and [15N-amino acid] selectively-labeled fusion proteins.  Further 
optimization of cleavage and purification allowed isolation of pure target peptides from 
one to two liters of culture in quantities sufficient for a complete NMR analysis.
In choosing the peptides to study we used a model of Ste2p36 to perform a 
computational analysis of the surface area buried between two consecutive TM domains 
without the connecting loops (Table 2). The two TMs of TM1-TM2 had the highest 
buried surface area of all of the double domain constructs, indicating the presence of 
many packing interactions (i.e. hydrogen bonding and hydrophobic interactions) and was 
expected to have a high tendency to fold to a unique tertiary structure under membrane 
mimetic conditions. In contrast to TM1-TM2, TM6-TM7-CT40 had a lower buried 
surface area. However, hydropathy analysis indicated that TM6-TM7-CT40 was more 
hydrophilic than TM1-TM2 because of the CT40 cytosolic tail extension at the carboxyl 
terminus. In previous studies, correlations have been presented between the 
hydrophilicity of a membrane peptide and its ease of purification. In the present case the 
decrease in the overall hydrophobicity of the target peptide did not increase our 
purification yields (see below).  This was likely due to the tendency of this peptide to 
aggregate even in the presence of detergent micelles (Figure 7), which may have led to 
irreversible losses on the reversed phase column. The TM6 domain has a very high 
hydrophobicity and this tendency to aggregate has been noted previously with single 
TM6 domain peptides4,48. Despite the challenges of its preparation, studies on TM6-
TM7-CT40 were a logical extension of our previous NMR investigations on EL3-TM7-
CT4027;28. Finally, both the TM1-TM2 and TM6-TM7-CT40 regions of Ste2p have been 
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shown to be important for interaction with the -factor ligand38,39 and signal 
transduction40 so structural analysis could be helpful in obtaining a better understanding 
of the molecular basis of receptor activation.
The most often used methods of isotopically labeling proteins require growth in 
defined minimal media to which sources of 15N, 13C or 2H are added. Such media can be 
extremely expensive.  As a rule, the lack of amino acids in minimal media reduces 
overall metabolism leading to slower growth and decreased protein expression.  In 
contrast we observed that for TM1-TM2 expression in LB and M9 media was similar in 
both BL21(DE3)pLysS and BL21-AI and TM6-TM7-CT40 actually expressed better in 
minimal medium (Figure 2C). Using these findings 15N and/or 15N/13C incorporation at 
high levels with excellent yields into both target peptides was achieved. In the presence 
of unlabelled amino acids in the M9 medium during selective labeling of TM1-TM2-FP 
we were able to generate up to 20 mg/L of TM1-TM2 after cleavage and purification. In 
a previous study a double TM peptide corresponding to TM1-TM2 of the cannabanoid 
receptor was isotopically labeled20, but yields of final peptide were only 0.8-2.5 mg/L.
We found that purification of the TM1-TM2-FP on a C3 column prior to release 
of the desired peptide by CNBr cleavage was a limiting step as only 0.5 mg of protein 
could be purified in each run because of sticking of the FP to the column. It is likely that 
the hydrophobic nature of the transmembrane domains of Ste2p cause extensive 
aggregation on the column.  This made the isolation of the fusion protein very inefficient 
and even under conditions we found to give the best recoveries we only isolated 8 mg/L 
of TM1-TM2-FP. This compares with 100 mg/L of the EL3-TM7-CT40 fusion protein 
we had studied previously27. Since the target peptide (TM1-TM2) represents only 40% of 
the mass of the FP, the theoretical yield of TM1-TM2 from 8 mg of TM1-TM2-FP would 
be limited to ~ 3 mg/L assuming 100% recovery. By cleaving the IB pellets with CNBr 
directly after solubilization in 70% aqueous TFA we were able to isolate pure TM1-TM2 
in amounts of 8-10 mg/L.  Using a similar protocol, we were only able to isolate 3 mg/L 
of TM6-TM7-CT40. Previous studies have also observed both poor CNBr cleavage 
yields of TM6-FP alone29 and a tendency of this peptide to aggregate4. Further 
optimization of cleavage and purification conditions or re-engineering of the CNBr 
cleavage site may increase the yields of TM6-TM7-FP, but at this point we have obtained 
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sufficient quantities of both double transmembrane containing peptides from a one liter 
fermentation to conduct CD and NMR analyses.
SDS-PAGE analyses were conducted to see whether TM1-TM2 would interact 
with TM6-TM7 to form a large microdomain of Ste2p. During these gel studies we 
observed that TM1-TM2 ran as a monomer whereas TM6-TM7 ran as a dimer. No 
evidence for interaction of TM1-TM2 with TM6-TM7 was obtained from this analysis. It 
is possible that the TM6-TM7-CT40 homodimerization may compete with and prevent 
the interaction of TM2 with TM7 under the conditions of our experiment, or that in this 
construct lipid-peptide contacts are more favorable than interactions between helices 
from the different peptides. These points require additional analyses. The results with 
TM1-TM2 may have biological relevance because based on BRET and FRET 
experiments Ste2p is thought to oligomerize via interactions involving the TM1 of this 
GPCR49-51. However, there is no experimental evidence concerning whether this 
interaction involves TM1 with itself or requires additional regions of the GPCR. The 
SDS-PAGE study indicates that under our experimental conditions TM1-TM1 
dimerization does not occur suggesting that either additional regions of the receptor are 
necessary for oligomerization or that the tertiary structure of TM1-TM2 in the SDS gel 
does not adequately reflect that of TM1 in the context of the complete GPCR in the yeast 
membrane.
Solubilization and refolding of the peptide for use in biophysical studies is a very 
important step in sample preparation.  For NMR analysis on integral membrane proteins 
two methods of solubilization and refolding: detergent exchange and reconstitution have 
been described in detail23. Our method is similar to the reconstitution method.  After 
purification under denaturing conditions, our peptides are lyophilized to remove the 
organic solvents in preparation for further study.  These dried peptides are then 
solubilized to give the desired peptide concentration in the detergent/buffer mixture of 
choice.  Most of the time this method works and the sample can be immediately used for 
CD or NMR analysis, but on occasion, sonication at 50°C is necessary to form a clear 
solution. Finally, if solubilization is still not achieved even after sonication, co-
lyophilization of the peptide in organic solvent and the detergent in water can be 
performed52.  This allows for the peptide to be coated with the detergent and when buffer 
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is added after lyophilization, the micelles form around the peptide thus allowing it to 
enter into solution for further biophysical analysis.
CD analysis was performed on both peptide fragments in multiple detergent 
micelles.  The TM1-TM2 peptide showed a high molar ellipticity in TFE/water, which 
was expected as helices are induced in this solvent53-55.  Based on splitting of the * 
transition, intensification of the 222 nm band and the overall ellipticities TM1-TM2 is 
largely -helical in SDS and LPPG micelles (Figure 6A).  Conversely, when studied in 
DPC micelles the CD pattern indicated either the presence of aggregates or multiple 
conformations.  The CD results with TM6-TM7-CT40 were similar, but the overall 
conformation in SDS and LPPG was less -helical as indicated by the reduced negative 
ellipticities at 208 nm and 222 nm and the decrease in positive ellipticity near 192 nm 
(Fig 7B). A CD analysis of the EL3-TM7-CT40 peptide27 also indicated this peptide had 
low overall helicity in the presence of detergent micelles. This is most likely due to the 
significant contribution from the mostly disordered structure of the 40 residues of the C-
terminal tail.
The HSQC spectra of TM1-TM2 and TM6-TM7-CT40 that were observed in the 
SDS and LPPG detergent micelles contained >90% of the expected peaks whereas the 
HSQC spectra in DPC showed only a few peaks for TM1-TM2 and approximately 40% 
of the expected peaks for TM6-TM7-CT40. Moreover these latter peaks were 
significantly broadened. In both cases conditions that had exhibited good -helical 
tendencies as judged by CD analysis led to well resolved HSQC spectra with relatively 
sharp peaks for these double TM containing fragments of Ste2p. The correlation between 
the helicity found in CD analysis in detergent micelles and the resolution and number of 
crosspeaks observed in the [15N,1H]-HSQC spectrum indicates that careful CD analysis in 
micellar mixtures is a good screening method to ascertain whether NMR of a peptide 
fragment would be feasible. Since CD is rapid and requires very little sample, ~ 0.1 mg 
peptide per CD measurement as compared with 0.7 mg of sample for HSQC 
measurements, and since CD is done on unlabelled samples which are relatively 
inexpensive to prepare, CD screening may greatly increase the efficiency of choosing a 
detergent for NMR studies. Selectively-labeled TM1-TM2 peptides were used in the 
[15N,1H]-HSQC analysis. These samples gave a high correlation with the peak positions 
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found in the HSQC spectrum of the uniformly labeled peptide and exhibited only a 
modest amount of scrambling of the 15N isotope into non labeled residues.  The 
correlation between the HSQC of the uniformly labeled and selectively labeled peptides 
would be consistent with reproducible sample preparation to give the same folded 
structure. This conclusion can only be tested by solving the complete tertiary structure of 
TM1-TM2 in LPPG.
In summary we have reported a strategy resulting in high levels of expression, 
cleavage, and purification of two double transmembrane domain containing peptides 
from a G protein-coupled receptor of S. cerevisiae.  The peptide fragments were purified 
in multi-milligram quantities allowing for screening of multiple detergent micelles using 
both CD and NMR analyses.  The CD analysis indicated that the peptides in two of three 
detergent micelles had largely helical tendencies which correlated to the ability to see 
HSQC spectra with good dispersion and >90% of the expected peaks.  Future screening 
of Ste2p peptide fragments in detergent micelles or lipid bicelles will initially be 
performed using CD to determine the viability of the medium for NMR investigations.  
Currently a complete structure determination of TM1-TM2 in LPPG micelles is being 
pursued.
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Figure Legends
Figure 1: Cartoon drawing of TM1-TM2 and TM6-TM7-CT40 double transmembrane 
domain constructs.  The predicted regions of secondary structure are indicated by the 
following: N-terminal region (NT), transmembrane domain (TM), intracellular loop (IL), 
extracellular loop (EL) and 40 residues of the C- terminal region (CT40).  The residue 
numbers are determined from the Ste2p sequence. Residues in gray circles have been 
mutated from the wild-type sequence. 
Figure 2: SDS-PAGE comparison of expression levels in three different E. coli
expression strains. A) TM1-TM2-FP and B) TM6-TM7-CT40-FP.  Expression was 
induced with either 1 mM IPTG or 0.2% L-arabinose (as indicated at the top of the gels) 
and grown at 37°C for 5 hours (TM1-TM2-FP) or 6 hours (TM6-TM7-CT40-FP) at 250 
rpm. Inclusion bodies were prepared for SDS-PAGE analysis as described27.  The 
predicted proteins are marked by an arrow and the expected MWs are A) 22.3 kDa for 
TM1-TM2-FP and B) 25.3 kDa for TM6-TM7-CT40-FP. C) Comparison of expression in 
LB and minimal media for both double domain fusion proteins in BL21-AI and 
BL21(DE3)pLysS.
Figure 3: Purification of TM1-TM2-FP from Inclusion Bodies.  A) The proteins 
solubilized from inclusion bodies were applied to a Zorbax 300-SB C3 Prep-HT column 
and separated by a 30-90% acetonitrile:water:0.1% TFA gradient at 50ºC, 5 ml/min.  The 
peak with a retention time of about 54 minutes (as indicated by the arrow) was collected, 
was observed to be homogeneous by analytic HPLC (B) and the MW was determined by 
ESI-MS (C).
Figure 4: Direct cleavage of inclusion bodies by CNBr.  A) IB pellets containing TM1-
TM2-FP were solubilized in 70% TFA and analyzed by HPLC  B) 1 M CNBr was added 
to the reaction and cleavage was followed over time (HPLC spectra at 1.5 to 4 hours were 
very similar) by analytical HPLC on a Zorbax 300-SB C3 column using a 40-80% 
solvent B gradient where solvent A was 90% water/10% isopropanol/0.1% TFA and 
solvent B was 90% acetonitrile/10% isopropanol/0.1% TFA at 60°C with a flow rate of 1 
Page 26 of 41
John Wiley & Sons, Inc.
Biopolymers: Peptide Science
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
27
ml/min. C) The peptide was purified on a Zorbax 300-SB C3 Prep-HT column and 
separated by a 50-90% solvent B gradient at 60°C with a flow rate of 5 ml/min.  ESI-MS 
was used to verify that the peptide was correct (MWcalculated=8751.29, 
MWobserved=8749.2).  
Figure 5:  Incorporation of the [15N]- and [15N,13C]- moieties was determined by ESI-MS. 
A) ESI-MS of [15N]-TM1-TM2 indicated that there was 96% incorporation of [15N] into 
the peptide (MWexpected=8852.29, MWobserved=8847.9).  The purity of the sample was 
observed by analytical HPLC as described above (Panel A, inset).  B) ESI-MS of 
[15N,13C]-TM1-TM2 indicated that there was 97% incorporation of both [15N] and [13C] 
into the peptide (MWexpected=9258.29, MWobserved=9240.5).  Expression levels were 
observed by SDS-PAGE analysis of IB pellets collected before and after induction (Panel 
B, inset).
Figure 6: CD of A) TM1-TM2 and B) TM6-TM7-CT40 in organic solvent and/or 
membrane mimetic micelles.  The concentration of both peptides was approximately 20-
25 µM and all analyses were done at room temperature with detergent:peptide ratios 
ranging from 100:1-200:1.
Figure 7: SDS-PAGE analysis of TM1-TM2 and TM6-TM7-CT40 in SDS micelles.  SDS 
micelles (10 mM or 100 mM) were prepared as described containing TM1-TM2 
(M1M2), TM6-TM7-CT40 (M6M7), or both double domain peptides (M1M2/M6M7).  
SDS-PAGE analysis was performed to determine the molecular state of the peptides 
within the micelle.  The MW of the individual peptides are: TM1-TM2 = 8.7 kDa and 
TM6-TM7-CT40 = 11.7 kDa.  Homodimers would have MWs of: 17.4 kDa or 23.4 kDa, 
respectively.  The presence of a heterodimer would be indicated by a band with a MW of 
20.4 kDa.  
Figure 8: [15N,1H]-HSQC spectra of [15N]-TM1-TM2 and [15N]-TM6-TM7-CT40 in 
LPPG (A and C, respectively) and SDS (B and D, respectively) recorded at 50ºC on 
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approximately 0.2 mM solutions of peptide with peptide:detergent molar ratios of 1:500.
The backbone and side chain amide resonances are both shown. 
Figure 9: [15N,1H]-HSQC spectra in LPPG of TM1-TM2 selectively labeled with [15N] 
amino acids. The same region of the HSQC spectrum of uniformly [15N]-labeled TM1-
TM2 is shown for comparison. (A) [15N-Ala]TM1-TM2 (B) [15N-Val]TM1-TM2 (C) 
[15N]-uniformly labeled TM1-TM2 and (D) [15N-Leu]TM1-TM2. Spectra were recorded 
at 50ºC on approximately 0.2 mM solutions of the peptides and peptide:LPPG molar 
ratios of 1:500.  The spectra were measured at 50ºC. Cross-labeled amino acids are 
indicated in boxes in (B).
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Table 1. Plasmids generated in this study.
Molecular Weight
(Da)
Name of Fusion Protein Plasmid Amino acid sequences encoded by plasmida,b
Fusion
Protein Peptide
TM1-TM2-FP pSWM1M2(C59S) MHHHHHHHHH-TrpLE-MGNGSTITFDELQGLVNSTVTQAIMFGVRSGAAALTLIVM-WMSRSRKTPIFIINQVSLFLIILHSALYFKYLLSNYSSVT 22383 8819.4
pSWM1M2(M54L,C59S) MHHHHHHHHH-TrpLE-MGNGSTITFDELQGLVNSTVTQAILFGVRSGAAALTLIVM-WMTSRSRKTPIFIINQVSLFLIILHSALYFKYLLSNYSSVT 22365 8801.4
pLC01 MHHHHHHHHH-TrpLE-MGNGSTITFDELQGLVNSTVTQAILFGVRSGAAALTLIVV-WITSRSRKTPIFIINQVSLFLIILHSALYFKYLLSNYSSVT 22315 8751.3
TM6-TM7-CT40-Trx-FP pKLS02
Thioredoxin•Tag-RSRRFLGLKQFDSFHILLIASSQSLLVPSIIFILAYSLKPNQ-
GTDVLTTVATLLAVLSLPLSSAWATAANNASKTNTITSDFTTSTDRFYPGTLSSFQTD-
SINNDAKSSLEHHHHHH
30128 12870.6
TM6-TM7-CT40-FP pREJ04
MHHHHHHHHH-TrpLE-MRSRRFLGLKQFDSFHILLIASSQSLLVPSIIFILAYSLK-
PNQGTDVLTTVATLLAVLSLPLSSAWATAANNASKTNTITSDFTTSTDRFYPGTLSSF-
QTDSINNDAKSS
25325 11760.4
aThe underlined regions represent the putative transmembrane domains.
bThe bolded letters are mutated Met or Cys (to S) residues residues.
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Table 2. Buried surface area analysis of consecutive double TM domain pairs.
Ste2p TM 
regions
Burieda
Surface Area 
(Å2)
TM1-TM2 1349
TM2-TM3 1254
TM3-TM4 869
TM6-TM7 845
TM5-TM6 794
TM4-TM5 472
a
 The surface area buried between each TM pair was calculated using a model for Ste2p36 and the NACCESS software41.
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Table 3. Expression Conditions for TM1-TM2-FP and Incorporation of [15N-Ala] into TM1-TM2 peptide.a
aSelectively labeled amino acids were incorporated into TM1-TM2 as described in the Materials and Methods and the percent
incorporation calculated using mass spectroscopy data.
ball amino acids added at 0.1 g/L
call amino acids added at 0.5 g/L
Selectively Labeled
Peptide Expression Conditions
% [15N]
in peptide
[15N-Ala] TM1-TM2 LB: 0.5 g/L [15N–Ala] 49%
[15N-Ala] TM1-TM2 minimal medium: 0.1 g/L [15N-Ala]b 21%
[15N-Ala] TM1-TM2 minimal medium: 0.5 g/L [15N-Ala]c 32%
[15N-Ala] TM1-TM2 52%
[15N-Ile] TM1-TM2 117%
[15N-Val] TM1-TM2 113%
[15N–Leu] TM1-TM2 104%
[15N-Phe] TM1-TM2
minimal medium without NH4Cl:
1 g/L [15N-AA]c
83%
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Table 4. TM6-TM7-CT40 cleavage using different CNBr concentrations for various times.
1M CNBr 2M CNBr
Time after CNBr added (h) 0 1 2 2.5 0 1 2
TM6-TM7-CT40FP peak areaa 7681 2771 1641 1384 8566 1890 1203
TM6-TM7-CT40 peak areaa 0 1394 1467 1518 0 1418 1542
% FP remaining 36 21 18 22 14
% TM6-TM7-CT40 generated compared to expected peptideb 40 42 43 36 39
aPeak areas were measured by HPLC using detection at 220 nm.
bThis was determined by multiplying the starting FP peak area by 46% because TM6-TM7-CT40 was 46% of the FP by weight.
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Figure 1: Cartoon drawing of TM1-TM2 and TM6-TM7-CT40 double transmembrane 
domain constructs. The predicted regions of secondary structure are indicated by the 
following: N-terminal region (NT), transmembrane domain (TM), intracellular loop (IL), 
extracellular loop (EL) and 40 residues of the C- terminal region (CT40). The residue 
numbers are determined from the Ste2p sequence. Residues in gray circles have been 
mutated from the wild-type sequence. 
Page 33 of 41
John Wiley & Sons, Inc.
Biopolymers: Peptide Science
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Figure 2: SDS-PAGE comparison of expression levels in three different E. coli expression 
strains. A) TM1-TM2-FP and B) TM6-TM7-CT40-FP. Expression was induced with either 1 
mM IPTG or 0.2% L-arabinose (as indicated at the top of the gels) and grown at 37 C for 
5 hours (TM1-TM2-FP) or 6 hours (TM6-TM7-CT40-FP) at 250 rpm. Inclusion bodies were 
prepared for SDS-PAGE analysis as described27. The predicted proteins are marked by an 
arrow and the expected MWs are A) 22.3 kDa for TM1-TM2-FP and B) 25.3 kDa for TM6-
TM7-CT40-FP. C) Comparison of expression in LB and minimal media for both double 
domain fusion proteins in BL21-AI and BL21(DE3)pLysS.  
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Figure 3: Purification of TM1-TM2-FP from Inclusion Bodies. A) The proteins solubilized 
from inclusion bodies were applied to a Zorbax 300-SB C3 Prep-HT column and separated 
by a 30-90% acetonitrile:water:0.1% TFA gradient at 50ºC, 5 ml/min. The peak with a 
retention time of about 54 minutes (as indicated by the arrow) was collected, was 
observed to be homogeneous by analytic HPLC (B) and the MW was determined by ESI-
MS (C). 
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Figure 4: Direct cleavage of inclusion bodies by CNBr. A) IB pellets containing TM1-TM2-
FP were solubilized in 70% TFA and analyzed by HPLC B) 1 M CNBr was added to the 
reaction and cleavage was followed over time (HPLC spectra at 1.5 to 4 hours were very 
similar) by analytical HPLC on a Zorbax 300-SB C3 column using a 40-80% solvent B 
gradient where solvent A was 90% water/10% isopropanol/0.1% TFA and solvent B was 
90% acetonitrile/10% isopropanol/0.1% TFA at 60 C with a flow rate of 1 ml/min. C) 
The peptide was purified on a Zorbax 300-SB C3 Prep-HT column and separated by a 50-
90% solvent B gradient at 60 C with a flow rate of 5 ml/min. ESI-MS was used to verify 
that the peptide was correct (MWcalculated=8751.29, MWobserved=8749.2).  
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Figure 5: Incorporation of the [15N]- and [15N,13C]- moieties was determined by ESI-MS. 
A) ESI-MS of [15N]-TM1-TM2 indicated that there was 96% incorporation of [15N] into the 
peptide (MWexpected=8852.29, MWobserved=8847.9). The purity of the sample was observed 
by analytical HPLC as described above (Panel A, inset). B) ESI-MS of [15N,13C]-TM1-TM2 
indicated that there was 97% incorporation of both [15N] and [13C] into the peptide 
(MWexpected=9258.29, MWobserved=9240.5). Expression levels were observed by SDS-PAGE 
analysis of IB pellets collected before and after induction (Panel B, inset). 
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Figure 6: CD of A) TM1-TM2 and B) TM6-TM7-CT40 in organic solvent and/or membrane 
mimetic micelles. The concentration of both peptides was approximately 20-25 M and 
all analyses were done at room temperature with detergent:peptide ratios ranging from 
100:1-200:1. 
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Figure 7: SDS-PAGE analysis of TM1-TM2 and TM6-TM7-CT40 in SDS micelles. SDS 
micelles (10 mM or 100 mM) were prepared as described containing TM1-TM2 (M1M2), 
TM6-TM7-CT40 (M6M7), or both double domain peptides (M1M2/M6M7). SDS-PAGE 
analysis was performed to determine the molecular state of the peptides within the 
micelle. The MW of the individual peptides are: TM1-TM2 = 8.7 kDa and TM6-TM7-CT40 = 
11.7 kDa. Homodimers would have MWs of: 17.4 kDa or 23.4 kDa, respectively. The 
presence of a heterodimer would be indicated by a band with a MW of 20.4 kDa.  
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Figure 8: [15N,1H]-HSQC spectra of [15N]-TM1-TM2 and [15N]-TM6-TM7-CT40 in LPPG (A 
and C, respectively) and SDS (B and D, respectively) recorded at 50ºC on approximately 
0.2 mM solutions of peptide with peptide:detergent molar ratios of 1:500. The backbone 
and side chain amide resonances are both shown.  
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Figure 9: [15N,1H]-HSQC spectra in LPPG of TM1-TM2 selectively labeled with [15N] amino 
acids. The same region of the HSQC spectrum of uniformly [15N]-labeled TM1-TM2 is 
shown for comparison. (A) [15N-Ala]TM1-TM2 (B) [15N-Val]TM1-TM2 (C) [15N]-uniformly 
labeled TM1-TM2 and (D) [15N-Leu]TM1-TM2. Spectra were recorded at 50ºC on 
approximately 0.2 mM solutions of the peptides and peptide:LPPG molar ratios of 1:500. 
The spectra were measured at 50ºC. Cross-labeled amino acids are indicated in boxes in 
(B). 
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